Suppression of autoimmune rheumatoid arthritis with hybrid nanoparticles that induce B and T cell tolerance to self-antigen
Autoimmune diseases affect over 4% of the world's population. Treatments are generally
palliative or use broad spectrum immunosuppressants to reduce symptoms and disease …
palliative or use broad spectrum immunosuppressants to reduce symptoms and disease …
Suppression of Autoimmune Rheumatoid Arthritis with Hybrid Nanoparticles That Induce B and T Cell Tolerance to Self-Antigen.
KA Brzezicka, BM Arlian, S Wang, M Olmer, M Lotz… - ACS Nano, 2022 - europepmc.org
Autoimmune diseases affect over 4% of the world's population. Treatments are generally
palliative or use broad spectrum immunosuppressants to reduce symptoms and disease …
palliative or use broad spectrum immunosuppressants to reduce symptoms and disease …
Suppression of Autoimmune Rheumatoid Arthritis with Hybrid Nanoparticles That Induce B and T Cell Tolerance to Self-Antigen
KA Brzezicka, BM Arlian, S Wang, M Olmer… - ACS …, 2022 - pubmed.ncbi.nlm.nih.gov
Autoimmune diseases affect over 4% of the world's population. Treatments are generally
palliative or use broad spectrum immunosuppressants to reduce symptoms and disease …
palliative or use broad spectrum immunosuppressants to reduce symptoms and disease …